On 29 October 2015

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 2015, to consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half Year ended 30 September 2015 (Q2).

Powered by Capital Market - Live News

More From This Section

First Published: Oct 16 2015 | 4:18 PM IST

Next Story